Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760

Watchlist Manager
Shenzhen Mindray Bio-Medical Electronics Co Ltd Logo
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Watchlist
Price: 195.77 CNY -1.13% Market Closed
Market Cap: 237.4B CNY

Shenzhen Mindray Bio-Medical Electronics Co Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Shenzhen Mindray Bio-Medical Electronics Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Revenue
ÂĄ33.1B
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Revenue
ÂĄ2.1B
CAGR 3-Years
36%
CAGR 5-Years
39%
CAGR 10-Years
N/A
iRay Technology Co Ltd
SSE:688301
Revenue
ÂĄ1.8B
CAGR 3-Years
16%
CAGR 5-Years
27%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Revenue
ÂĄ8.1B
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
15%
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Revenue
ÂĄ6.3B
CAGR 3-Years
-14%
CAGR 5-Years
-6%
CAGR 10-Years
10%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Revenue
ÂĄ10.3B
CAGR 3-Years
12%
CAGR 5-Years
28%
CAGR 10-Years
N/A
No Stocks Found

Shenzhen Mindray Bio-Medical Electronics Co Ltd
Glance View

In the bustling city of Shenzhen, China, a thriving enterprise known as Shenzhen Mindray Bio-Medical Electronics Co., Ltd, has cemented its place within the global medical devices market. Born in 1991 amid the backdrop of China’s rapid economic expansion, Mindray embarked on an ambitious journey to revolutionize healthcare technology. The company operates across three main segments: patient monitoring and life support, in-vitro diagnostics, and medical imaging systems. Each category is crucial to the medical infrastructure, with patient monitoring systems tracking vital statistics in real-time, in-vitro diagnostics facilitating intricate lab testing, and medical imaging enabling precise internal examinations. The synergy among these segments allows Mindray to deliver comprehensive solutions that enhance both the quality and efficiency of healthcare systems worldwide. Mindray's business model is intrinsically tied to innovation and global distribution. The company continually invests in research and development, a strategic move that keeps it at the forefront of medical technology advancement. Its R&D centers — strategically located in China, the U.S., and Europe — work tirelessly to push the boundaries of medical technology and address the evolving needs of healthcare professionals. In tandem with its technological prowess, Mindray crafts a robust network of distribution that ensures its advanced devices reach hospitals and clinics across over 190 countries. This expansive market presence, coupled with competitive pricing strategies, has propelled the company to secure a formidable foothold in both emerging and developed economies, thereby transforming the accessibility and delivery of healthcare services on a global scale.

Intrinsic Value
236.49 CNY
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Shenzhen Mindray Bio-Medical Electronics Co Ltd's Revenue?
Revenue
33.1B CNY

Based on the financial report for Sep 30, 2025, Shenzhen Mindray Bio-Medical Electronics Co Ltd's Revenue amounts to 33.1B CNY.

What is Shenzhen Mindray Bio-Medical Electronics Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
10%

Over the last year, the Revenue growth was -11%. The average annual Revenue growth rates for Shenzhen Mindray Bio-Medical Electronics Co Ltd have been 4% over the past three years , 10% over the past five years .

Back to Top